516
Participants
Start Date
January 31, 2007
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
fesoterodine fumarate
12 weeks of study treatment: Subjects received fesoterodine tablets 4 mg once daily for 4 weeks; thereafter, daily dosage was maintained at 4 mg or increased to 8 mg based on subject's and physician's subjective assessment of efficacy and tolerability.
Pfizer Investigational Site, New York
Pfizer Investigational Site, Kingston
Pfizer Investigational Site, Poughkeepsie
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Sellersville
Pfizer Investigational Site, Winston-Salem
Pfizer Investigational Site, West Palm Beach
Pfizer Investigational Site, Marburg
Pfizer Investigational Site, Homewood
Pfizer Investigational Site, Huntsville
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Muelheim A.d. Ruhr
Pfizer Investigational Site, Duisburg
Pfizer Investigational Site, Dnipropetrovsk
Pfizer Investigational Site, Milwaukee
Pfizer Investigational Site, Alzey
Pfizer Investigational Site, Chernivtsi
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Kharkiv
Pfizer Investigational Site, Odesa
Pfizer Investigational Site, Frankfurt
Pfizer Investigational Site, Pratt
Pfizer Investigational Site, Omaha
Pfizer Investigational Site, Zaporizhzhia
Pfizer Investigational Site, Shreveport
Pfizer Investigational Site, Bethany
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, München
Pfizer Investigational Site, Salt Lake City
Pfizer Investigational Site, Salt Lake City
Pfizer Investigational Site, La Mesa
Pfizer Investigational Site, Orangevale
Pfizer Investigational Site, Eugene
Pfizer Investigational Site, Milford
Pfizer Investigational Site, Woodlane
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Edegem
Pfizer Investigational Site, Ghent
Pfizer Investigational Site, Jette
Pfizer Investigational Site, Turnhout
Pfizer Investigational Site, Alajuela Centro
Pfizer Investigational Site, San José
Pfizer Investigational Site, Brno-Bohunice
Pfizer Investigational Site, Hradec Králové
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Lodz
Pfizer Investigational Site, Mysłowice
Pfizer Investigational Site, Bratislava
Pfizer Investigational Site, Malacky
Pfizer Investigational Site, Piešťany
Pfizer Investigational Site, Prešov
Pfizer Investigational Site, Skalica
Pfizer Investigational Site, Bucheon-si
Pfizer Investigational Site, Busan
Pfizer Investigational Site, Daejeon
Pfizer Investigational Site, Jeonnam
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Lead Sponsor
Pfizer
INDUSTRY